Recombinant Human SEI-1 protein is a Human Full Length protein, in the 1 to 236 aa range, expressed in Escherichia coli, with >85% purity and suitable for SDS-PAGE, MS.
M G S S H H H H H H S S G L V P R G S H M G S H M L S K G L K R K R E E E E E K E P L A V D S W W L D P G H T A V A Q A P P A V A S S S L F D L S V L K L H H S L Q Q S E P D L R H L V L V V N T L R R I Q A S M A P A A A L P P V P S P P A A P S V A D N L L A S S D A A L S A S M A S L L E D L S H I E G L S Q A P Q P L A D E G P P G R S I G G A A P S L G A L D L L G P A T G C L L D D G L E G L F E D I D T S M Y D N E L W A P A S E G L K P G P E D G P G K E E A P E L D E A E L D Y L M D V L V G T Q A L E R P P G P G R
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Application MS | Reactivity Reacts | Dilution info - | Notes - |
Acts at E2F-responsive promoters as coregulator to integrate signals provided by PHD- and/or bromodomain-containing transcription factors. Stimulates E2F1/TFDP1 transcriptional activity. Renders the activity of cyclin D1/CDK4 resistant to the inhibitory effects of CDKN2A/p16INK4A.
SEI1, TRIPBR1, SERTAD1, SERTA domain-containing protein 1, CDK4-binding protein p34SEI1, Transcriptional regulator interacting with the PHD-bromodomain 1, SEI-1, p34(SEI-1), TRIP-Br1
Recombinant Human SEI-1 protein is a Human Full Length protein, in the 1 to 236 aa range, expressed in Escherichia coli, with >85% purity and suitable for SDS-PAGE, MS.
pH: 8
Constituents: 10% Glycerol (glycerin, glycerine), 0.32% Tris HCl, 0.02% (R*,R*)-1,4-Dimercaptobutan-2,3-diol
ab130022 was purified using conventional chromatography.
Acts at E2F-responsive promoters as coregulator to integrate signals provided by PHD- and/or bromodomain-containing transcription factors. Stimulates E2F1/TFDP1 transcriptional activity. Renders the activity of cyclin D1/CDK4 resistant to the inhibitory effects of CDKN2A/p16INK4A.
Polyubiquitinated, which promotes proteasomal degradation.
Previously labelled as Sertad1.
SEI-1 also known as p34SEI-1 or CDK4-binding protein p34 is an important protein involved in cell cycle regulation. It has a molecular mass of approximately 31 kDa. Expression of SEI-1 occurs in various tissues with a noticeable presence in proliferative tissues like the thymus spleen and certain cancerous tissues. It exerts its role mechanistically by interacting with cyclin-dependent kinases (CDKs) particularly CDK4 and modulating their activity during cell cycle progression.
SEI-1 influences cell cycle regulation and proliferation. It acts as a regulatory factor for the CDK4/Cyclin D1 complex facilitating the G1 to S phase transition in the cell cycle. This protein by interacting directly with CDK4 plays a part in the assembly and activation of CDK4 complexes which are pivotal for proper cell division. SEI-1 also has a role outside the cell cycle like apoptosis regulation hinting at diverse functionality within cellular processes.
SEI-1 sits prominently in the cell cycle control pathway. It associates closely with the retinoblastoma protein (Rb) pathway where its modulation of CDK4 activity influences Rb phosphorylation. SEI-1’s interaction with CDK4 links it to both the MAP kinase (MAPK) and PI3K/Akt signaling pathways impacting cell growth and survival. Through these associations SEI-1 contributes importantly to the regulation of cellular proliferation and survival mechanisms.
SEI-1 shows connections to cancer particularly in its overexpression found in several cancer types such as breast cancer and gliomas. Its ability to amplify CDK4 activity and deregulate the cell cycle links SEI-1 with oncogenesis. Therapeutic interest targets its interaction with CDK4 to control cancer cell proliferation. SEI-1 also associates with diabetes as its pathway involvement connects to insulin signaling potentially influencing insulin resistance. In both conditions the protein may serve as a potential biomarker or target for new therapeutic strategies.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
15% SDS-PAGE analysis of 3 μg ab130022.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com